SCHEMBL5664809

SCHEMBL5664809

COCCOC1=CC(=O)C(N)=C(c2ncnc3ccccc23)C1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LDHA P00338 1/20 0.40
KDR P35968 10/20 0.39
KDM1A O60341 2/20 0.36
ADORA2A P29274 1/20 0.36
PI4KA P42356 1/20 0.35
PI4K2B Q8TCG2 1/20 0.35
PI4K2A Q9BTU6 1/20 0.35
PI4KB Q9UBF8 1/20 0.35
RAB9A P51151 2/20 0.34
NPC1 O15118 1/20 0.34
TSHR P16473 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
MPO P05164 1/20 0.34
TDP2 O95551 1/20 0.34
NSD2 O96028 1/20 0.34
PAX8 Q06710 1/20 0.34
HKDC1 Q2TB90 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5134656 0.83 LDHA (0.42) LDHAKDM1AADORA2API4KAPI4K2B
SCHEMBL5664944 0.81 KDR (0.43) KDRKDM1ATDP2NSD2PAX8
SCHEMBL5135030 0.81 GAPDH (0.42) KDRKDM1AADORA2API4KAPI4K2B
SCHEMBL5134741 0.79 MAP4K4 (0.39) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL5135024 0.78 ADORA2A (0.43) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL5135029 0.72 GAPDH (0.43) KDRKDM1AADORA2API4KAPI4K2B
SCHEMBL5135022 0.72 ADORA2A (0.44) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL5135370 0.72 CES1 (0.47) KDRADORA2ARAB9ANPC1
SCHEMBL5134739 0.71 MAP4K4 (0.40) ADORA2API4KAPI4K2BPI4K2API4KB
SCHEMBL5135298 0.70 APAF1 (0.42) ADORA2API4KAPI4K2BPI4K2API4KB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors WYETH (US) 2007-12-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070299092-A1 Quinone Substituted Quinazoline and Quinoline Kinase Inhibitors KDR, FLT1, FLT4 LDHA 1551/4885KDR 1/4885KDM1A 1435/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.